Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Athersys Inc (NQ: ATHX ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 17, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Athersys Inc < Previous 1 2 3 4 5 6 7 8 9 Next > The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales February 02, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News January 31, 2022 The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. Via Benzinga Athersys to Host a Virtual Presentation on Its MultiStem® Programs January 26, 2022 From Athersys, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session January 21, 2022 Gainers Idera Pharmaceuticals (NASDAQ:IDRA) stock rose 13.0% to $0.71 during Friday's pre-market session. The market value of their outstanding shares is at $37.7... Via Benzinga Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer January 20, 2022 From Athersys, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session January 20, 2022 Gainers TCR2 Therapeutics (NASDAQ:TCRR) s... Via Benzinga Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases January 05, 2022 Palm Beach, FL – January 5, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an... Via FinancialNewsMedia Topics Death Exposures Death Athersys Shares Jump After MultiStem Cell Therapy Data Published In Medical Journal November 30, 2021 Athersys Inc (NASDAQ: ATHX) announced that a manuscript reporting data from its MUST-ARDS clinical trial have been published in the peer-reviewed medical journal,... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday November 30, 2021 Good morning, investor! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers you need to know about! Via InvestorPlace Exposures Product Safety Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine November 30, 2021 From Athersys, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session November 22, 2021 Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session November 19, 2021 Gainers CASI Pharmaceuticals (NASDAQ:CASI Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session November 19, 2021 Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... Via Benzinga Athersys (ATHX) Q3 2021 Earnings Call Transcript November 16, 2021 ATHX earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Athersys Reports Third Quarter 2021 Results and Provides Corporate Update November 15, 2021 From Athersys, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 November 19, 2021 Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE: Via Benzinga The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More November 14, 2021 Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares November 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday November 12, 2021 Good morning! We're kicking off the final day of the trading week with an overview of the biggest pre-market stock movers for Monday! Via InvestorPlace Athersys Reports Updates on Timing for Japan ARDS and Stroke Programs From Healios K.K. November 12, 2021 From Athersys Via Business Wire Athersys to Host Third Quarter Financial Results Call October 18, 2021 From Athersys, Inc. Via Business Wire The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO October 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... Via Benzinga Exposures Product Safety Athersys to Present at 2021 Cell & Gene Meeting on the Mesa Hybrid Conference September 28, 2021 From Athersys, Inc. Via Business Wire The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug September 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... Via Benzinga Exposures COVID-19 How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients August 13, 2021 Via FinancialNewsMedia Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke August 10, 2021 From Athersys, Inc. Via Business Wire Athersys (ATHX) Q2 2021 Earnings Call Transcript August 10, 2021 ATHX earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Athersys: Q2 Earnings Insights August 09, 2021 Shares of Athersys (NASDAQ:ATHX) increased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the... Via Benzinga Athersys Reports Second Quarter 2021 Results August 09, 2021 From Athersys, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.